Navigating Market Access With Magnolia: February 26, 2026 Webinar Sign Up
Integrating HEOR and Payer Considerations in Clinical Trial Design to Improve Access
Thursday, February 26, 2026 | 12:00 – 1:00 PM ET
"*" indicates required fields
Integrating HEOR and Payer Considerations in Clinical Trial Design to Improve Access
Thursday, February 26, 2026 | 12:00 PM ET
Getting FDA approval is a critical milestone, but it does not guarantee that patients will be able to access a therapy. Clinical trial design for market access is becoming increasingly important as payers place growing pressure on manufacturers to demonstrate value beyond clinical outcomes, including real-world relevance, economic impact, and clear differentiation from existing treatment options.
Join Christine Molbury, Jessica Duchen, and Anna Hundt Golden for a practical discussion on how market access and HEOR considerations can be built into clinical trial strategy earlier in development. They will share perspectives on how payer expectations are evolving, where evidence gaps commonly emerge, and how cross-functional alignment can help avoid access challenges later in the product lifecycle.
Key Takeaways:
Why Attend:
Whether you are responsible for clinical development, value and evidence strategy, or commercialization planning, this webinar will provide actionable insights to help strengthen access outcomes.
